387520007: Bendroflumethiazide (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Diuretic (substance)\Thiazide diuretic (substance)\Bendroflumethiazide (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Organic cyclic compound\Heterocyclic compound (substance)\Thiazide (substance)\Benzothiadiazine\Bendroflumethiazide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bendroflumethiazide (substance)	Is a	Thiazide diuretic (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide (substance)	Is a	Benzothiadiazine	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bendroflumethiazide measurement	Component	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendrofluazide poisoning (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Accidental bendrofluazide poisoning (disorder)	Causative agent (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Intentional bendrofluazide poisoning	Causative agent (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendrofluazide poisoning of undetermined intent	Causative agent (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendrofluazide adverse reaction	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendrofluazide allergy	Causative agent (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendrofluazide overdose	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Accidental bendrofluazide overdose (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Intentional bendrofluazide overdose (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendrofluazide overdose of undetermined intent	Causative agent (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide 5mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide + nadolol 5mg/40mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide + nadolol 5mg/80mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing bendroflumethiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide- and nadolol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Timolol maleate+bendroflumethiazide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide- and potassium-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Propranolol hydrochloride + bendrofluazide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide + nadolol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Accidental bendrofluazide poisoning (disorder)	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Intentional bendrofluazide poisoning	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing atenolol and bendroflumethiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide- and propranolol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing bendroflumethiazide and timolol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendrofluazide+potassium 2.5mg/8.4mmol m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendrofluazide allergy	Causative agent (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide prophylaxis	Direct substance	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 2.5 mg oral tablet	Has basis of strength substance (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg oral tablet	Has basis of strength substance (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	Has basis of strength substance (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule	Has basis of strength substance (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	Has basis of strength substance (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	Has basis of strength substance (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	Has basis of strength substance (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	Has basis of strength substance (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule	Has basis of strength substance (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 2.5 mg and potassium chloride 573 mg prolonged-release oral tablet	Has basis of strength substance (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 2.5 mg and potassium chloride 573 mg prolonged-release oral tablet	Has precise active ingredient	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Has precise active ingredient	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Has basis of strength substance (attribute)	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 2.5 mg oral tablet	Has precise active ingredient	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg oral tablet	Has precise active ingredient	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Atenolol- and bendroflumethiazide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule	Has precise active ingredient	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	Has precise active ingredient	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	Has precise active ingredient	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	Has precise active ingredient	False	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing bendroflumethiazide and timolol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing bendroflumethiazide and potassium chloride in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide- and propranolol-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide- and potassium chloride-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only atenolol and bendroflumethiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only bendroflumethiazide and nadolol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide and potassium only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only bendroflumethiazide and potassium chloride (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide and propranolol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only bendroflumethiazide and timolol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only atenolol and bendroflumethiazide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide and nadolol only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide and potassium chloride only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide and propranolol only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only bendroflumethiazide and timolol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	Has precise active ingredient	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet	Has precise active ingredient	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Has basis of strength substance (attribute)	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Has precise active ingredient	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide prophylaxis	Direct substance	True	Bendroflumethiazide (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461698010	Bendroflumethiazide (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481610010	Bendroflumethiazide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492142019	Bendrofluazide	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1492143012	Benzydroflumethiazide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1461698010	Bendroflumethiazide (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461698010	Bendroflumethiazide (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481610010	Bendroflumethiazide	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1481610010	Bendroflumethiazide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492142019	Bendrofluazide	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1492142019	Bendrofluazide	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1492143012	Benzydroflumethiazide	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1492143012	Benzydroflumethiazide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
402001000274114	Bendroflumethiazid	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
793791000172114	bendrofluméthiazide	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
793791000172114	bendrofluméthiazide	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
402001000274114	Bendroflumethiazid	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module